v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Federal grants $ 279,351 $ 1,200,816 $ 1,089,920 $ 1,895,907
Operating expenses:        
Research and development 4,756,096 1,714,635 13,393,948 2,502,232
General and administrative 1,686,580 16,372,976 5,717,281 17,257,361
Total operating expenses 6,442,676 18,087,611 19,111,229 19,759,593
Loss from operations (6,163,325) (16,886,795) (18,021,309) (17,863,686)
Other income (expense):        
Issuance costs for convertible notes (1,118,721) (500,158) (1,118,721) (500,158)
Change in fair value of derivative liabilities 673,314
Loss on issuance of convertible notes (3,609,944) (3,609,944)
Change in fair value of convertible notes 3,491,513 1,071,099 6,169,929 1,071,099
Issuance of liability classified warrants (3,737,371) (1,325,804) (3,737,371) (1,325,804)
Change in fair value of liability classified warrants 2,683,340 405,086 5,626,130 405,086
Loss on debt conversions (1,404,877) (4,000,155)
Interest expense (4,859) (24,660) (57,662) (1,282,820)
Loss on extinguishment of debt (347,566)
Other income and expense, net 8,679 61,758 19,494 61,758
Total other income (expense), net (3,692,240) (312,679) (708,300) (1,245,091)
Net loss (9,855,565) (17,199,474) (18,729,609) (19,108,777)
Net loss attributable to noncontrolling interests (21,492) (35,948) (47,619) (61,976)
Deemed dividend related to warrants down round provision 63,539 881,598
Net loss attributable to common stockholders $ (9,897,612) $ (17,163,526) $ (19,563,588) $ (19,046,801)
Net loss per share:        
Net loss per share attributable to common stockholders, basic and diluted $ (5.13) $ (14.15) $ (11.74) $ (20.31)
Weighted average common shares outstanding, basic and diluted 1,928,727 1,212,791 1,666,253 937,764

Source